JANUS HENDERSON GROUP PLC OWNS 5.9% OF AMICUS THERAPEUTICS

Company

AMICUS THERAPEUTICS, INC.

Filed

February 12, 2019

Accession Number

0001274173-19-000085

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →